Prognostic Implication of BCR-ABL Fusion Transcript Variants in Chronic Myeloid Leukemia (CML) Treated with Imatinib. A First of Its Kind Study on CML Patients of Kashmir

BACKGROUND: The prognostic significance of the common BCR-ABL transcripts like e13a2 (b2a2) and e14a2 (b3a2) in Chronic myeloid leukemia (CML) has been reported from patients treated with different tyrosine kinase inhibitors but its impact on clinical response and overall survival remains still unex...

Descripción completa

Detalles Bibliográficos
Autores principales: Azad, Niyaz A, Shah, Zafar A, Pandith, Arshad A, Khan, Mosin S, Rasool, Roohi, Rasool, Javed, Aziz, Shiekh A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103580/
https://www.ncbi.nlm.nih.gov/pubmed/29936718
http://dx.doi.org/10.22034/APJCP.2018.19.6.1479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103580/
https://www.ncbi.nlm.nih.gov/pubmed/29936718
http://dx.doi.org/10.22034/APJCP.2018.19.6.1479

Ejemplares similares